Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 34

1.

Inequity In Organ Allocation For Patients Awaiting Liver Transplantation: Rationale for Uncapping the Model for End-Stage Liver Disease.

Nadim MK, DiNorcia J, Ji L, Groshen S, Levitsky J, Sung RS, Kim WR, Andreoni K, Mulligan D, Genyk YS.

J Hepatol. 2017 May 5. pii: S0168-8278(17)32003-2. doi: 10.1016/j.jhep.2017.04.022. [Epub ahead of print]

PMID:
28483678
2.

Sustained Reduction of Blood Pressure With Baroreceptor Activation Therapy: Results of the 6-Year Open Follow-Up.

de Leeuw PW, Bisognano JD, Bakris GL, Nadim MK, Haller H, Kroon AA; DEBuT-HT and Rheos Trial Investigators..

Hypertension. 2017 May;69(5):836-843. doi: 10.1161/HYPERTENSIONAHA.117.09086. Epub 2017 Mar 20.

PMID:
28320856
3.

What endpoints should be used for clinical studies in acute kidney injury?

Kellum JA, Zarbock A, Nadim MK.

Intensive Care Med. 2017 Mar 2. doi: 10.1007/s00134-017-4732-1. [Epub ahead of print] No abstract available.

PMID:
28255614
4.

Perioperative Renal Replacement Therapy in Liver Transplantation.

DiNorcia J, Meouchy J, Genyk YS, Nadim MK.

Int Anesthesiol Clin. 2017 Spring;55(2):81-91. doi: 10.1097/AIA.0000000000000136. No abstract available.

PMID:
28225534
5.

An exploratory propensity score matched comparison of second-generation and first-generation baroreflex activation therapy systems.

Wachter R, Halbach M, Bakris GL, Bisognano JD, Haller H, Beige J, Kroon AA, Nadim MK, Lovett EG, Schafer JE, de Leeuw PW.

J Am Soc Hypertens. 2017 Feb;11(2):81-91. doi: 10.1016/j.jash.2016.12.003. Epub 2016 Dec 16.

6.

Corrigendum to "Management of the critically ill patients with cirrhosis: A multidisciplinary perspective".

Nadim MK, Durand F, Kellum JA, Levitsky J, O'Leary JG, Karvellas CJ, Bajaj JS, Davenport A, Jalan R, Angeli P, Caldwell SH, Fernández J, Francoz C, Garcia-Tsao G, Ginès P, Ison MG, Kramer DJ, Mehta RL, Moreau R, Mulligan D, Olson JC, Pomfret EA, Senzolo M, Steadman RH, Subramanian RM, Vincent JL, Genyk YS.

J Hepatol. 2016 May 27. pii: S0168-8278(16)30185-4. doi: 10.1016/j.jhep.2016.05.001. [Epub ahead of print] No abstract available.

PMID:
27241199
7.

Kidney biomarkers in cirrhosis.

Francoz C, Nadim MK, Durand F.

J Hepatol. 2016 Oct;65(4):809-24. doi: 10.1016/j.jhep.2016.05.025. Epub 2016 May 26. Review.

PMID:
27238754
8.

Management of Acute-on-Chronic Liver Failure.

Durand F, Nadim MK.

Semin Liver Dis. 2016 May;36(2):141-52. doi: 10.1055/s-0036-1583198. Epub 2016 May 12.

PMID:
27172356
9.

Protecting the Kidney in Liver Transplant Candidates: Practice-Based Recommendations From the American Society of Transplantation Liver and Intestine Community of Practice.

O'Leary JG, Levitsky J, Wong F, Nadim MK, Charlton M, Kim WR.

Am J Transplant. 2016 Sep;16(9):2516-31. doi: 10.1111/ajt.13790. Epub 2016 May 13. Review.

PMID:
26990924
10.

Management of the critically ill patient with cirrhosis: A multidisciplinary perspective.

Nadim MK, Durand F, Kellum JA, Levitsky J, O'Leary JG, Karvellas CJ, Bajaj JS, Davenport A, Jalan R, Angeli P, Caldwell SH, Fernández J, Francoz C, Garcia-Tsao G, Ginès P, Ison MG, Kramer DJ, Mehta RL, Moreau R, Mulligan D, Olson JC, Pomfret EA, Senzolo M, Steadman RH, Subramanian RM, Vincent JL, Genyk YS.

J Hepatol. 2016 Mar;64(3):717-35. doi: 10.1016/j.jhep.2015.10.019. Epub 2015 Oct 28. Review. No abstract available.

PMID:
26519602
11.

Pathogenesis of Hepatorenal Syndrome: Implications for Therapy.

Durand F, Graupera I, Ginès P, Olson JC, Nadim MK.

Am J Kidney Dis. 2016 Feb;67(2):318-28. doi: 10.1053/j.ajkd.2015.09.013. Epub 2015 Oct 21. Review.

PMID:
26500178
12.

Acute Kidney Injury in Cirrhosis.

Karvellas CJ, Durand F, Nadim MK.

Crit Care Clin. 2015 Oct;31(4):737-50. doi: 10.1016/j.ccc.2015.06.009. Epub 2015 Aug 5. Review.

PMID:
26410141
13.

8B.06: BAROREFLEX ACTIVATION THERAPY CONSISTENTLY MAINTAINS BLOOD PRESSURE REDUCTION IN A LARGE RESISTANT HYPERTENSION COHORT FOR AT LEAST 6 YEARS.

de Leeuw PW, Bakris GL, Nadim MK, Haller H, Lovett EG, Bisognano JD.

J Hypertens. 2015 Jun;33 Suppl 1:e108. doi: 10.1097/01.hjh.0000467642.47246.de.

PMID:
26102672
14.

Hepatorenal Disorders.

Al-Khafaji A, Nadim MK, Kellum JA.

Chest. 2015 Aug;148(2):550-8. doi: 10.1378/chest.14-1925. Review.

PMID:
25811649
15.

Renal Denervation in Heart Failure.

Fong MW, Shavelle D, Weaver FA, Nadim MK.

Curr Hypertens Rep. 2015 Mar;17(3):17. doi: 10.1007/s11906-014-0528-7. Review.

PMID:
25754320
16.

Resistant hypertension: medical management and alternative therapies.

Ghofrani H, Weaver FA, Nadim MK.

Cardiol Clin. 2015 Feb;33(1):75-87. doi: 10.1016/j.ccl.2014.09.003. Review.

PMID:
25439332
17.

Intraoperative hemodialysis during liver transplantation: a decade of experience.

Nadim MK, Annanthapanyasut W, Matsuoka L, Appachu K, Boyajian M, Ji L, Sedra A, Genyk YS.

Liver Transpl. 2014 Jul;20(7):756-64. doi: 10.1002/lt.23867.

18.

Glomerular filtration rate equations for liver-kidney transplantation in patients with cirrhosis: validation of current recommendations.

Francoz C, Nadim MK, Baron A, Prié D, Antoine C, Belghiti J, Valla D, Moreau R, Durand F.

Hepatology. 2014 Apr;59(4):1514-21. doi: 10.1002/hep.26704. Epub 2014 Mar 3.

PMID:
24037821
19.

Simultaneous liver-kidney transplantation summit: current state and future directions.

Nadim MK, Sung RS, Davis CL, Andreoni KA, Biggins SW, Danovitch GM, Feng S, Friedewald JJ, Hong JC, Kellum JA, Kim WR, Lake JR, Melton LB, Pomfret EA, Saab S, Genyk YS.

Am J Transplant. 2012 Nov;12(11):2901-8. doi: 10.1111/j.1600-6143.2012.04190.x. Epub 2012 Jul 23. Review.

20.

Simultaneous liver-kidney transplantation: a survey of US transplant centers.

Nadim MK, Davis CL, Sung R, Kellum JA, Genyk YS.

Am J Transplant. 2012 Nov;12(11):3119-27. doi: 10.1111/j.1600-6143.2012.04176.x. Epub 2012 Jul 3.

Supplemental Content

Loading ...
Support Center